tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Boston Scientific price target raised to $127 from $124 at BTIG

BTIG raised the firm’s price target on Boston Scientific (BSX) to $127 from $124 and keeps a Buy rating on the shares following the Q2 beat. The company can continue to outperform “sky-high expectations” through new products and clinical data, the analyst tells investors in a research note.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1